![](/img/cover-not-exists.png)
Open-Label Study to Assess the Efficacy of Ipragliflozin for Reducing Insulin Dose in Patients with Type 2 Diabetes Mellitus Receiving Insulin Therapy
Ishihara, Hisamitsu, Yamaguchi, Susumu, Sugitani, Toshifumi, Kosakai, YoshinoriLanguage:
english
Journal:
Clinical Drug Investigation
DOI:
10.1007/s40261-019-00851-z
Date:
September, 2019
File:
PDF, 880 KB
english, 2019